nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—ACVR1—pes—gout	0.0359	0.181	CbGeAlD
Crizotinib—ABCB1—Colchicine—gout	0.0302	0.114	CbGbCtD
Crizotinib—ABCB1—Probenecid—gout	0.027	0.102	CbGbCtD
Crizotinib—ABCB1—Methylprednisolone—gout	0.0267	0.101	CbGbCtD
Crizotinib—ABCB1—Indomethacin—gout	0.0263	0.0995	CbGbCtD
Crizotinib—CYP3A5—Hydrocortisone—gout	0.0249	0.0942	CbGbCtD
Crizotinib—CYP3A4—Colchicine—gout	0.0181	0.0684	CbGbCtD
Crizotinib—BMP2K—synovial membrane of synovial joint—gout	0.0171	0.0862	CbGeAlD
Crizotinib—ABCB1—Prednisolone—gout	0.0171	0.0647	CbGbCtD
Crizotinib—RIPK2—synovial membrane of synovial joint—gout	0.0164	0.0826	CbGeAlD
Crizotinib—ABCB1—Hydrocortisone—gout	0.0162	0.0613	CbGbCtD
Crizotinib—CYP3A4—Probenecid—gout	0.0162	0.0612	CbGbCtD
Crizotinib—ABCB1—Prednisone—gout	0.0162	0.0611	CbGbCtD
Crizotinib—CYP3A4—Methylprednisolone—gout	0.016	0.0604	CbGbCtD
Crizotinib—ROS1—tendon—gout	0.0105	0.0528	CbGeAlD
Crizotinib—CYP3A4—Prednisolone—gout	0.0102	0.0388	CbGbCtD
Crizotinib—CYP3A4—Hydrocortisone—gout	0.00972	0.0367	CbGbCtD
Crizotinib—CYP3A4—Prednisone—gout	0.00968	0.0366	CbGbCtD
Crizotinib—MUSK—tendon—gout	0.00893	0.0449	CbGeAlD
Crizotinib—LIMK1—tendon—gout	0.00469	0.0236	CbGeAlD
Crizotinib—MAPK7—tendon—gout	0.00422	0.0212	CbGeAlD
Crizotinib—FES—tendon—gout	0.00418	0.021	CbGeAlD
Crizotinib—MET—tendon—gout	0.00395	0.0199	CbGeAlD
Crizotinib—TAOK2—tendon—gout	0.00379	0.0191	CbGeAlD
Crizotinib—DCLK1—tendon—gout	0.00346	0.0174	CbGeAlD
Crizotinib—FER—tendon—gout	0.00323	0.0163	CbGeAlD
Crizotinib—TNK1—tendon—gout	0.0032	0.0161	CbGeAlD
Crizotinib—MAP4K1—tendon—gout	0.00317	0.0159	CbGeAlD
Crizotinib—MAP4K2—tendon—gout	0.00306	0.0154	CbGeAlD
Crizotinib—STK3—tendon—gout	0.00302	0.0152	CbGeAlD
Crizotinib—AURKA—tendon—gout	0.00294	0.0148	CbGeAlD
Crizotinib—TESK1—tendon—gout	0.00292	0.0147	CbGeAlD
Crizotinib—MERTK—tendon—gout	0.00284	0.0143	CbGeAlD
Crizotinib—MAP3K12—tendon—gout	0.00275	0.0138	CbGeAlD
Crizotinib—ACVR1—tendon—gout	0.00275	0.0138	CbGeAlD
Crizotinib—STK35—tendon—gout	0.00269	0.0135	CbGeAlD
Crizotinib—ABL2—tendon—gout	0.00262	0.0132	CbGeAlD
Crizotinib—BMP2K—tendon—gout	0.00259	0.013	CbGeAlD
Crizotinib—PTK2B—tendon—gout	0.0025	0.0126	CbGeAlD
Crizotinib—RIPK2—tendon—gout	0.00248	0.0125	CbGeAlD
Crizotinib—EPHA4—tendon—gout	0.0024	0.0121	CbGeAlD
Crizotinib—Hypokalaemia—Allopurinol—gout	0.00233	0.00652	CcSEcCtD
Crizotinib—Lymphopenia—Prednisone—gout	0.00233	0.0065	CcSEcCtD
Crizotinib—PTK2—tendon—gout	0.00231	0.0116	CbGeAlD
Crizotinib—TBK1—tendon—gout	0.00231	0.0116	CbGeAlD
Crizotinib—TYK2—tendon—gout	0.00229	0.0115	CbGeAlD
Crizotinib—IRAK1—tendon—gout	0.00226	0.0114	CbGeAlD
Crizotinib—Neuropathy peripheral—Colchicine—gout	0.00225	0.00628	CcSEcCtD
Crizotinib—Diplopia—Naproxen—gout	0.00224	0.00626	CcSEcCtD
Crizotinib—RPS6KB1—tendon—gout	0.00222	0.0112	CbGeAlD
Crizotinib—FGR—tendon—gout	0.0022	0.0111	CbGeAlD
Crizotinib—AXL—tendon—gout	0.0022	0.011	CbGeAlD
Crizotinib—Neuropathy peripheral—Indomethacin—gout	0.00214	0.00597	CcSEcCtD
Crizotinib—SLK—tendon—gout	0.00211	0.0106	CbGeAlD
Crizotinib—EPHB4—tendon—gout	0.0021	0.0106	CbGeAlD
Crizotinib—JAK2—tendon—gout	0.00208	0.0105	CbGeAlD
Crizotinib—Neutropenia—Allopurinol—gout	0.00207	0.00579	CcSEcCtD
Crizotinib—Abscess—Prednisolone—gout	0.00207	0.00578	CcSEcCtD
Crizotinib—EPHA2—tendon—gout	0.00206	0.0104	CbGeAlD
Crizotinib—Hypoaesthesia—Colchicine—gout	0.00205	0.00572	CcSEcCtD
Crizotinib—Hypokalaemia—Naproxen—gout	0.00204	0.00569	CcSEcCtD
Crizotinib—Abscess—Hydrocortisone—gout	0.00202	0.00565	CcSEcCtD
Crizotinib—Dizziness—Probenecid—gout	0.00202	0.00563	CcSEcCtD
Crizotinib—MAP3K3—tendon—gout	0.00201	0.0101	CbGeAlD
Crizotinib—TEK—tendon—gout	0.00201	0.0101	CbGeAlD
Crizotinib—MAP4K5—tendon—gout	0.00201	0.0101	CbGeAlD
Crizotinib—Bradycardia—Indomethacin—gout	0.00199	0.00556	CcSEcCtD
Crizotinib—Febrile neutropenia—Prednisone—gout	0.00198	0.00553	CcSEcCtD
Crizotinib—Muscular weakness—Naproxen—gout	0.00198	0.00552	CcSEcCtD
Crizotinib—JAK2—Factors involved in megakaryocyte development and platelet production—LRRC16A—gout	0.00196	0.0116	CbGpPWpGaD
Crizotinib—IRAK1—NOD1/2 Signaling Pathway—CASP1—gout	0.00195	0.0116	CbGpPWpGaD
Crizotinib—Vomiting—Probenecid—gout	0.00194	0.00542	CcSEcCtD
Crizotinib—Neuropathy peripheral—Allopurinol—gout	0.00194	0.00541	CcSEcCtD
Crizotinib—Eye disorder—Colchicine—gout	0.00192	0.00537	CcSEcCtD
Crizotinib—Dermatitis—Probenecid—gout	0.00192	0.00537	CcSEcCtD
Crizotinib—EPHB6—tendon—gout	0.00192	0.00965	CbGeAlD
Crizotinib—Abscess—Methylprednisolone—gout	0.0019	0.00531	CcSEcCtD
Crizotinib—TEK—Hemostasis—LRRC16A—gout	0.00188	0.0112	CbGpPWpGaD
Crizotinib—CYP3A5—Irinotecan Pathway—ABCG2—gout	0.00188	0.0112	CbGpPWpGaD
Crizotinib—Hepatobiliary disease—Allopurinol—gout	0.00187	0.00522	CcSEcCtD
Crizotinib—ABCB1—Abacavir transport and metabolism—ABCG2—gout	0.00186	0.011	CbGpPWpGaD
Crizotinib—Mediastinal disorder—Colchicine—gout	0.00185	0.00518	CcSEcCtD
Crizotinib—YES1—tendon—gout	0.00185	0.00933	CbGeAlD
Crizotinib—STK3—MAPK Signaling Pathway—CASP1—gout	0.00185	0.011	CbGpPWpGaD
Crizotinib—IGF1R—Apoptosis—CASP1—gout	0.00185	0.011	CbGpPWpGaD
Crizotinib—STK10—tendon—gout	0.00184	0.00924	CbGeAlD
Crizotinib—TAOK3—tendon—gout	0.00183	0.00921	CbGeAlD
Crizotinib—Nausea—Probenecid—gout	0.00181	0.00506	CcSEcCtD
Crizotinib—RIPK2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP1—gout	0.00181	0.0108	CbGpPWpGaD
Crizotinib—IRAK1—IL1-mediated signaling events—CASP1—gout	0.00181	0.0107	CbGpPWpGaD
Crizotinib—Bradycardia—Allopurinol—gout	0.00181	0.00505	CcSEcCtD
Crizotinib—Malnutrition—Colchicine—gout	0.00179	0.005	CcSEcCtD
Crizotinib—Hypoaesthesia—Allopurinol—gout	0.00177	0.00493	CcSEcCtD
Crizotinib—Urinary tract disorder—Allopurinol—gout	0.00175	0.0049	CcSEcCtD
Crizotinib—Weight decreased—Naproxen—gout	0.00175	0.00489	CcSEcCtD
Crizotinib—IRAK1—IL1-mediated signaling events—IL1RN—gout	0.00175	0.0104	CbGpPWpGaD
Crizotinib—Arrhythmia—Indomethacin—gout	0.00175	0.00488	CcSEcCtD
Crizotinib—Urethral disorder—Allopurinol—gout	0.00174	0.00486	CcSEcCtD
Crizotinib—Pneumonia—Naproxen—gout	0.00174	0.00485	CcSEcCtD
Crizotinib—Visual impairment—Allopurinol—gout	0.00171	0.00478	CcSEcCtD
Crizotinib—Neuropathy peripheral—Naproxen—gout	0.00169	0.00473	CcSEcCtD
Crizotinib—Eye disorder—Allopurinol—gout	0.00166	0.00463	CcSEcCtD
Crizotinib—Anaemia—Colchicine—gout	0.00166	0.00463	CcSEcCtD
Crizotinib—MAP3K12—MAPK Signaling Pathway—CASP1—gout	0.00165	0.00982	CbGpPWpGaD
Crizotinib—Cardiac disorder—Allopurinol—gout	0.00165	0.0046	CcSEcCtD
Crizotinib—Hepatobiliary disease—Naproxen—gout	0.00163	0.00456	CcSEcCtD
Crizotinib—Vision blurred—Indomethacin—gout	0.0016	0.00448	CcSEcCtD
Crizotinib—Leukopenia—Colchicine—gout	0.0016	0.00448	CcSEcCtD
Crizotinib—CSF1R—tendon—gout	0.0016	0.00806	CbGeAlD
Crizotinib—Anaemia—Indomethacin—gout	0.00157	0.0044	CcSEcCtD
Crizotinib—MET—Direct p53 effectors—CASP1—gout	0.00156	0.00926	CbGpPWpGaD
Crizotinib—Fluid retention—Prednisolone—gout	0.00156	0.00435	CcSEcCtD
Crizotinib—ACVR1B—MAPK Signaling Pathway—CASP1—gout	0.00155	0.00923	CbGpPWpGaD
Crizotinib—Malnutrition—Allopurinol—gout	0.00154	0.00432	CcSEcCtD
Crizotinib—Neuropathy—Prednisolone—gout	0.00154	0.0043	CcSEcCtD
Crizotinib—IRAK1—Interleukin-1 signaling—IL1RN—gout	0.00154	0.00914	CbGpPWpGaD
Crizotinib—Urinary tract disorder—Naproxen—gout	0.00153	0.00427	CcSEcCtD
Crizotinib—Syncope—Indomethacin—gout	0.00153	0.00426	CcSEcCtD
Crizotinib—Oedema peripheral—Naproxen—gout	0.00153	0.00426	CcSEcCtD
Crizotinib—Leukopenia—Indomethacin—gout	0.00152	0.00426	CcSEcCtD
Crizotinib—Fluid retention—Hydrocortisone—gout	0.00152	0.00424	CcSEcCtD
Crizotinib—Urethral disorder—Naproxen—gout	0.00152	0.00424	CcSEcCtD
Crizotinib—Dysgeusia—Allopurinol—gout	0.00151	0.00423	CcSEcCtD
Crizotinib—Abscess—Prednisone—gout	0.0015	0.0042	CcSEcCtD
Crizotinib—Neuropathy—Hydrocortisone—gout	0.0015	0.0042	CcSEcCtD
Crizotinib—Loss of consciousness—Indomethacin—gout	0.0015	0.00418	CcSEcCtD
Crizotinib—Visual impairment—Naproxen—gout	0.00149	0.00417	CcSEcCtD
Crizotinib—Eye disorder—Naproxen—gout	0.00145	0.00404	CcSEcCtD
Crizotinib—Shock—Colchicine—gout	0.00144	0.00402	CcSEcCtD
Crizotinib—Cardiac disorder—Naproxen—gout	0.00144	0.00402	CcSEcCtD
Crizotinib—Nervous system disorder—Colchicine—gout	0.00143	0.00401	CcSEcCtD
Crizotinib—Anaemia—Allopurinol—gout	0.00143	0.00399	CcSEcCtD
Crizotinib—Fluid retention—Methylprednisolone—gout	0.00143	0.00399	CcSEcCtD
Crizotinib—JAK3—Hemostasis—LRRC16A—gout	0.00142	0.00845	CbGpPWpGaD
Crizotinib—Skin disorder—Colchicine—gout	0.00142	0.00397	CcSEcCtD
Crizotinib—Neuropathy—Methylprednisolone—gout	0.00141	0.00394	CcSEcCtD
Crizotinib—Mediastinal disorder—Naproxen—gout	0.0014	0.0039	CcSEcCtD
Crizotinib—Oedema—Indomethacin—gout	0.00139	0.00388	CcSEcCtD
Crizotinib—Arrhythmia—Naproxen—gout	0.00138	0.00387	CcSEcCtD
Crizotinib—Leukopenia—Allopurinol—gout	0.00138	0.00386	CcSEcCtD
Crizotinib—Shock—Indomethacin—gout	0.00137	0.00382	CcSEcCtD
Crizotinib—Malnutrition—Naproxen—gout	0.00135	0.00377	CcSEcCtD
Crizotinib—IRAK1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP1—gout	0.00133	0.00789	CbGpPWpGaD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Allopurinol—gout	0.00131	0.00365	CcSEcCtD
Crizotinib—Decreased appetite—Colchicine—gout	0.00127	0.00355	CcSEcCtD
Crizotinib—Vision blurred—Naproxen—gout	0.00127	0.00355	CcSEcCtD
Crizotinib—ABL1—tendon—gout	0.00127	0.00637	CbGeAlD
Crizotinib—Gastrointestinal disorder—Colchicine—gout	0.00126	0.00353	CcSEcCtD
Crizotinib—Oedema—Allopurinol—gout	0.00126	0.00352	CcSEcCtD
Crizotinib—Fatigue—Colchicine—gout	0.00126	0.00352	CcSEcCtD
Crizotinib—Visual disturbance—Prednisolone—gout	0.00126	0.00351	CcSEcCtD
Crizotinib—Blood alkaline phosphatase increased—Methylprednisolone—gout	0.00125	0.0035	CcSEcCtD
Crizotinib—Infection—Allopurinol—gout	0.00125	0.0035	CcSEcCtD
Crizotinib—Paraesthesia—Indomethacin—gout	0.00125	0.00349	CcSEcCtD
Crizotinib—Anaemia—Naproxen—gout	0.00125	0.00348	CcSEcCtD
Crizotinib—Dyspnoea—Indomethacin—gout	0.00124	0.00346	CcSEcCtD
Crizotinib—Nervous system disorder—Allopurinol—gout	0.00124	0.00345	CcSEcCtD
Crizotinib—Skin disorder—Allopurinol—gout	0.00122	0.00342	CcSEcCtD
Crizotinib—Dyspepsia—Indomethacin—gout	0.00122	0.00342	CcSEcCtD
Crizotinib—FGR—Hemostasis—LRRC16A—gout	0.00121	0.00722	CbGpPWpGaD
Crizotinib—LYN—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.00121	0.00721	CbGpPWpGaD
Crizotinib—Syncope—Naproxen—gout	0.00121	0.00338	CcSEcCtD
Crizotinib—Decreased appetite—Indomethacin—gout	0.00121	0.00337	CcSEcCtD
Crizotinib—ABL1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.00121	0.00718	CbGpPWpGaD
Crizotinib—Leukopenia—Naproxen—gout	0.00121	0.00337	CcSEcCtD
Crizotinib—Fatigue—Indomethacin—gout	0.0012	0.00335	CcSEcCtD
Crizotinib—Constipation—Indomethacin—gout	0.00119	0.00332	CcSEcCtD
Crizotinib—Loss of consciousness—Naproxen—gout	0.00119	0.00331	CcSEcCtD
Crizotinib—MAP3K3—Signaling by Interleukins—CASP1—gout	0.00116	0.00691	CbGpPWpGaD
Crizotinib—RPS6KB1—Leptin signaling pathway—IL1RN—gout	0.00116	0.00689	CbGpPWpGaD
Crizotinib—TXK—Innate Immune System—NLRP3—gout	0.00115	0.00685	CbGpPWpGaD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Naproxen—gout	0.00114	0.00319	CcSEcCtD
Crizotinib—Paraesthesia—Allopurinol—gout	0.00113	0.00316	CcSEcCtD
Crizotinib—Fluid retention—Prednisone—gout	0.00113	0.00316	CcSEcCtD
Crizotinib—MAP3K3—Signaling by Interleukins—IL1RN—gout	0.00113	0.00669	CbGpPWpGaD
Crizotinib—Neuropathy—Prednisone—gout	0.00112	0.00312	CcSEcCtD
Crizotinib—Dyspepsia—Allopurinol—gout	0.00111	0.0031	CcSEcCtD
Crizotinib—JAK2—IFN-gamma pathway—CASP1—gout	0.0011	0.00655	CbGpPWpGaD
Crizotinib—Oedema—Naproxen—gout	0.0011	0.00307	CcSEcCtD
Crizotinib—Body temperature increased—Indomethacin—gout	0.0011	0.00307	CcSEcCtD
Crizotinib—Decreased appetite—Allopurinol—gout	0.0011	0.00306	CcSEcCtD
Crizotinib—JAK3—Signaling by Interleukins—CASP1—gout	0.0011	0.00652	CbGpPWpGaD
Crizotinib—Infection—Naproxen—gout	0.00109	0.00305	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Allopurinol—gout	0.00109	0.00304	CcSEcCtD
Crizotinib—Shock—Naproxen—gout	0.00108	0.00303	CcSEcCtD
Crizotinib—Nervous system disorder—Naproxen—gout	0.00108	0.00302	CcSEcCtD
Crizotinib—Constipation—Allopurinol—gout	0.00108	0.00301	CcSEcCtD
Crizotinib—BLK—Apoptosis Modulation and Signaling—CASP1—gout	0.00108	0.00641	CbGpPWpGaD
Crizotinib—Skin disorder—Naproxen—gout	0.00107	0.00299	CcSEcCtD
Crizotinib—JAK3—Signaling by Interleukins—IL1RN—gout	0.00106	0.00631	CbGpPWpGaD
Crizotinib—Hypokalaemia—Hydrocortisone—gout	0.00106	0.00295	CcSEcCtD
Crizotinib—Asthenia—Colchicine—gout	0.00105	0.00293	CcSEcCtD
Crizotinib—Muscular weakness—Prednisolone—gout	0.00105	0.00293	CcSEcCtD
Crizotinib—MAPK7—MAPK Signaling Pathway—CASP1—gout	0.00104	0.00619	CbGpPWpGaD
Crizotinib—Sepsis—Prednisone—gout	0.00103	0.00289	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Hydrocortisone—gout	0.00102	0.00286	CcSEcCtD
Crizotinib—Muscular weakness—Hydrocortisone—gout	0.00102	0.00286	CcSEcCtD
Crizotinib—EPHA2—Direct p53 effectors—CASP1—gout	0.001	0.00597	CbGpPWpGaD
Crizotinib—Diarrhoea—Colchicine—gout	0.001	0.00279	CcSEcCtD
Crizotinib—Asthenia—Indomethacin—gout	0.000997	0.00278	CcSEcCtD
Crizotinib—Body temperature increased—Allopurinol—gout	0.000997	0.00278	CcSEcCtD
Crizotinib—PTK2—Leptin signaling pathway—IL1RN—gout	0.000994	0.00591	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—LRRC16A—gout	0.000993	0.00591	CbGpPWpGaD
Crizotinib—Paraesthesia—Naproxen—gout	0.000988	0.00276	CcSEcCtD
Crizotinib—PRKD1—Metabolism—BCKDHA—gout	0.000988	0.00588	CbGpPWpGaD
Crizotinib—Dyspnoea—Naproxen—gout	0.000981	0.00274	CcSEcCtD
Crizotinib—YES1—Hemostasis—LRRC16A—gout	0.00098	0.00583	CbGpPWpGaD
Crizotinib—RIPK2—Signaling by Interleukins—CASP1—gout	0.000977	0.00581	CbGpPWpGaD
Crizotinib—Dyspepsia—Naproxen—gout	0.000969	0.00271	CcSEcCtD
Crizotinib—PTK2B—Signaling by Interleukins—CASP1—gout	0.000963	0.00572	CbGpPWpGaD
Crizotinib—Muscular weakness—Methylprednisolone—gout	0.000962	0.00269	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Methylprednisolone—gout	0.000962	0.00269	CcSEcCtD
Crizotinib—Decreased appetite—Naproxen—gout	0.000957	0.00267	CcSEcCtD
Crizotinib—Diarrhoea—Indomethacin—gout	0.000951	0.00266	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Naproxen—gout	0.00095	0.00265	CcSEcCtD
Crizotinib—Fatigue—Naproxen—gout	0.000949	0.00265	CcSEcCtD
Crizotinib—MAP3K2—MAPK Signaling Pathway—CASP1—gout	0.000949	0.00564	CbGpPWpGaD
Crizotinib—MAP4K1—MAPK Signaling Pathway—CASP1—gout	0.000949	0.00564	CbGpPWpGaD
Crizotinib—RIPK2—Signaling by Interleukins—IL1RN—gout	0.000946	0.00562	CbGpPWpGaD
Crizotinib—Constipation—Naproxen—gout	0.000941	0.00263	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Hydrocortisone—gout	0.000933	0.00261	CcSEcCtD
Crizotinib—PTK2B—Signaling by Interleukins—IL1RN—gout	0.000932	0.00554	CbGpPWpGaD
Crizotinib—Vomiting—Colchicine—gout	0.00093	0.0026	CcSEcCtD
Crizotinib—Rash—Colchicine—gout	0.000922	0.00258	CcSEcCtD
Crizotinib—Dermatitis—Colchicine—gout	0.000921	0.00257	CcSEcCtD
Crizotinib—Dizziness—Indomethacin—gout	0.000919	0.00257	CcSEcCtD
Crizotinib—Weight decreased—Hydrocortisone—gout	0.000908	0.00254	CcSEcCtD
Crizotinib—Asthenia—Allopurinol—gout	0.000905	0.00253	CcSEcCtD
Crizotinib—Neuropathy peripheral—Prednisolone—gout	0.000898	0.00251	CcSEcCtD
Crizotinib—Infestation NOS—Hydrocortisone—gout	0.000895	0.0025	CcSEcCtD
Crizotinib—Infestation—Hydrocortisone—gout	0.000895	0.0025	CcSEcCtD
Crizotinib—Vomiting—Indomethacin—gout	0.000883	0.00247	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Hydrocortisone—gout	0.000879	0.0834	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Hydrocortisone—gout	0.000879	0.0834	CbGdCrCtD
Crizotinib—Neuropathy peripheral—Hydrocortisone—gout	0.000877	0.00245	CcSEcCtD
Crizotinib—Rash—Indomethacin—gout	0.000876	0.00245	CcSEcCtD
Crizotinib—Dermatitis—Indomethacin—gout	0.000875	0.00244	CcSEcCtD
Crizotinib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000874	0.0052	CbGpPWpGaD
Crizotinib—IKBKE—Innate Immune System—NLRP3—gout	0.000874	0.00519	CbGpPWpGaD
Crizotinib—Body temperature increased—Naproxen—gout	0.00087	0.00243	CcSEcCtD
Crizotinib—Nausea—Colchicine—gout	0.000869	0.00243	CcSEcCtD
Crizotinib—Diarrhoea—Allopurinol—gout	0.000863	0.00241	CcSEcCtD
Crizotinib—Infestation NOS—Methylprednisolone—gout	0.000841	0.00235	CcSEcCtD
Crizotinib—Infestation—Methylprednisolone—gout	0.000841	0.00235	CcSEcCtD
Crizotinib—Bradycardia—Prednisolone—gout	0.000838	0.00234	CcSEcCtD
Crizotinib—Face oedema—Prednisone—gout	0.000834	0.00233	CcSEcCtD
Crizotinib—Dizziness—Allopurinol—gout	0.000834	0.00233	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Methylprednisolone—gout	0.00083	0.0787	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Methylprednisolone—gout	0.00083	0.0787	CbGdCrCtD
Crizotinib—Nausea—Indomethacin—gout	0.000825	0.00231	CcSEcCtD
Crizotinib—Neuropathy peripheral—Methylprednisolone—gout	0.000824	0.0023	CcSEcCtD
Crizotinib—IRAK1—Apoptosis Modulation and Signaling—CASP1—gout	0.000822	0.00489	CbGpPWpGaD
Crizotinib—Bradycardia—Hydrocortisone—gout	0.000818	0.00229	CcSEcCtD
Crizotinib—PRKD1—Metabolism—PRPS2—gout	0.000806	0.00479	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—PRPS1—gout	0.000806	0.00479	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—HPRT1—gout	0.000806	0.00479	CbGpPWpGaD
Crizotinib—Vomiting—Allopurinol—gout	0.000802	0.00224	CcSEcCtD
Crizotinib—Rash—Allopurinol—gout	0.000795	0.00222	CcSEcCtD
Crizotinib—MAPK7—Innate Immune System—NLRP3—gout	0.000795	0.00473	CbGpPWpGaD
Crizotinib—LIMK1—Innate Immune System—NLRP3—gout	0.000795	0.00473	CbGpPWpGaD
Crizotinib—Dermatitis—Allopurinol—gout	0.000794	0.00222	CcSEcCtD
Crizotinib—Visual impairment—Prednisolone—gout	0.000793	0.00221	CcSEcCtD
Crizotinib—Asthenia—Naproxen—gout	0.00079	0.00221	CcSEcCtD
Crizotinib—Hypokalaemia—Prednisone—gout	0.000787	0.0022	CcSEcCtD
Crizotinib—Bradycardia—Methylprednisolone—gout	0.000769	0.00215	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Prednisone—gout	0.000762	0.00213	CcSEcCtD
Crizotinib—Muscular weakness—Prednisone—gout	0.000762	0.00213	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Prednisone—gout	0.000757	0.0718	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Prednisone—gout	0.000757	0.0718	CbGdCrCtD
Crizotinib—YES1—Signaling by Interleukins—CASP1—gout	0.000756	0.00449	CbGpPWpGaD
Crizotinib—Diarrhoea—Naproxen—gout	0.000753	0.0021	CcSEcCtD
Crizotinib—Eye disorder—Hydrocortisone—gout	0.000751	0.0021	CcSEcCtD
Crizotinib—Nausea—Allopurinol—gout	0.000749	0.00209	CcSEcCtD
Crizotinib—SRC—Syndecan-3-mediated signaling events—POMC—gout	0.000743	0.00442	CbGpPWpGaD
Crizotinib—ACVR1—Betamethasone—Prednisolone—gout	0.000739	0.0701	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Prednisolone—gout	0.000739	0.0701	CbGdCrCtD
Crizotinib—Arrhythmia—Prednisolone—gout	0.000735	0.00205	CcSEcCtD
Crizotinib—YES1—Signaling by Interleukins—IL1RN—gout	0.000732	0.00435	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—LRRC16A—gout	0.000731	0.00434	CbGpPWpGaD
Crizotinib—Dizziness—Naproxen—gout	0.000728	0.00203	CcSEcCtD
Crizotinib—Visual impairment—Methylprednisolone—gout	0.000728	0.00203	CcSEcCtD
Crizotinib—ABL1—Hemostasis—LRRC16A—gout	0.000727	0.00432	CbGpPWpGaD
Crizotinib—Arrhythmia—Hydrocortisone—gout	0.000718	0.00201	CcSEcCtD
Crizotinib—IRAK1—Signaling by Interleukins—CASP1—gout	0.000717	0.00426	CbGpPWpGaD
Crizotinib—Eye disorder—Methylprednisolone—gout	0.000706	0.00197	CcSEcCtD
Crizotinib—Cardiac disorder—Methylprednisolone—gout	0.000701	0.00196	CcSEcCtD
Crizotinib—Vomiting—Naproxen—gout	0.0007	0.00196	CcSEcCtD
Crizotinib—Malnutrition—Hydrocortisone—gout	0.0007	0.00195	CcSEcCtD
Crizotinib—Neutropenia—Prednisone—gout	0.000698	0.00195	CcSEcCtD
Crizotinib—TYK2—Signaling by Interleukins—CASP1—gout	0.000696	0.00414	CbGpPWpGaD
Crizotinib—IRAK1—Signaling by Interleukins—IL1RN—gout	0.000694	0.00413	CbGpPWpGaD
Crizotinib—Rash—Naproxen—gout	0.000694	0.00194	CcSEcCtD
Crizotinib—Dermatitis—Naproxen—gout	0.000693	0.00194	CcSEcCtD
Crizotinib—JAK2—Leptin signaling pathway—IL1RN—gout	0.000684	0.00407	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—LRRC16A—gout	0.000684	0.00407	CbGpPWpGaD
Crizotinib—Mediastinal disorder—Methylprednisolone—gout	0.00068	0.0019	CcSEcCtD
Crizotinib—Weight decreased—Prednisone—gout	0.000676	0.00189	CcSEcCtD
Crizotinib—Vision blurred—Prednisolone—gout	0.000675	0.00189	CcSEcCtD
Crizotinib—Arrhythmia—Methylprednisolone—gout	0.000674	0.00188	CcSEcCtD
Crizotinib—TYK2—Signaling by Interleukins—IL1RN—gout	0.000674	0.00401	CbGpPWpGaD
Crizotinib—TXK—Immune System—NLRP3—gout	0.000671	0.00399	CbGpPWpGaD
Crizotinib—Malnutrition—Methylprednisolone—gout	0.000657	0.00184	CcSEcCtD
Crizotinib—Nausea—Naproxen—gout	0.000654	0.00183	CcSEcCtD
Crizotinib—Neuropathy peripheral—Prednisone—gout	0.000653	0.00182	CcSEcCtD
Crizotinib—TBK1—Innate Immune System—NLRP3—gout	0.000649	0.00386	CbGpPWpGaD
Crizotinib—NTRK1—MAPK Signaling Pathway—CASP1—gout	0.000647	0.00385	CbGpPWpGaD
Crizotinib—Syncope—Prednisolone—gout	0.000642	0.00179	CcSEcCtD
Crizotinib—Loss of consciousness—Prednisolone—gout	0.00063	0.00176	CcSEcCtD
Crizotinib—Syncope—Hydrocortisone—gout	0.000627	0.00175	CcSEcCtD
Crizotinib—Loss of consciousness—Hydrocortisone—gout	0.000615	0.00172	CcSEcCtD
Crizotinib—Bradycardia—Prednisone—gout	0.000609	0.0017	CcSEcCtD
Crizotinib—LCK—Hemostasis—LRRC16A—gout	0.000599	0.00356	CbGpPWpGaD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	0.000591	0.00165	CcSEcCtD
Crizotinib—Syncope—Methylprednisolone—gout	0.000589	0.00165	CcSEcCtD
Crizotinib—Oedema—Prednisolone—gout	0.000585	0.00163	CcSEcCtD
Crizotinib—Loss of consciousness—Methylprednisolone—gout	0.000578	0.00161	CcSEcCtD
Crizotinib—Shock—Prednisolone—gout	0.000575	0.00161	CcSEcCtD
Crizotinib—Oedema—Hydrocortisone—gout	0.000571	0.00159	CcSEcCtD
Crizotinib—Infection—Hydrocortisone—gout	0.000567	0.00158	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Hydrocortisone—gout	0.000567	0.0537	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Hydrocortisone—gout	0.000567	0.0537	CbGdCrCtD
Crizotinib—LYN—Signaling by Interleukins—CASP1—gout	0.000564	0.00335	CbGpPWpGaD
Crizotinib—TXK—Innate Immune System—CASP1—gout	0.000563	0.00335	CbGpPWpGaD
Crizotinib—Shock—Hydrocortisone—gout	0.000562	0.00157	CcSEcCtD
Crizotinib—Nervous system disorder—Hydrocortisone—gout	0.00056	0.00156	CcSEcCtD
Crizotinib—Eye disorder—Prednisone—gout	0.000559	0.00156	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	0.000556	0.00155	CcSEcCtD
Crizotinib—Skin disorder—Hydrocortisone—gout	0.000555	0.00155	CcSEcCtD
Crizotinib—LYN—Signaling by Interleukins—IL1RN—gout	0.000546	0.00325	CbGpPWpGaD
Crizotinib—MAP3K3—Cytokine Signaling in Immune system—CASP1—gout	0.000542	0.00322	CbGpPWpGaD
Crizotinib—TESK1—Betamethasone—Methylprednisolone—gout	0.000535	0.0507	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Methylprednisolone—gout	0.000535	0.0507	CbGdCrCtD
Crizotinib—Arrhythmia—Prednisone—gout	0.000534	0.00149	CcSEcCtD
Crizotinib—Infection—Methylprednisolone—gout	0.000533	0.00149	CcSEcCtD
Crizotinib—SRC—Leptin signaling pathway—IL1RN—gout	0.00053	0.00315	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—LRRC16A—gout	0.00053	0.00315	CbGpPWpGaD
Crizotinib—Shock—Methylprednisolone—gout	0.000528	0.00147	CcSEcCtD
Crizotinib—JAK2—Signaling by Interleukins—CASP1—gout	0.000527	0.00314	CbGpPWpGaD
Crizotinib—Nervous system disorder—Methylprednisolone—gout	0.000526	0.00147	CcSEcCtD
Crizotinib—MAP3K3—Cytokine Signaling in Immune system—IL1RN—gout	0.000525	0.00312	CbGpPWpGaD
Crizotinib—Paraesthesia—Prednisolone—gout	0.000525	0.00147	CcSEcCtD
Crizotinib—RIPK2—Innate Immune System—NLRP3—gout	0.000523	0.00311	CbGpPWpGaD
Crizotinib—Skin disorder—Methylprednisolone—gout	0.000521	0.00146	CcSEcCtD
Crizotinib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000521	0.0031	CbGpPWpGaD
Crizotinib—Malnutrition—Prednisone—gout	0.00052	0.00145	CcSEcCtD
Crizotinib—Paraesthesia—Hydrocortisone—gout	0.000513	0.00143	CcSEcCtD
Crizotinib—JAK3—Cytokine Signaling in Immune system—CASP1—gout	0.000511	0.00304	CbGpPWpGaD
Crizotinib—JAK2—Signaling by Interleukins—IL1RN—gout	0.000511	0.00304	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—NLRP3—gout	0.000509	0.00303	CbGpPWpGaD
Crizotinib—Dyspepsia—Hydrocortisone—gout	0.000503	0.0014	CcSEcCtD
Crizotinib—FGR—Innate Immune System—NLRP3—gout	0.000502	0.00298	CbGpPWpGaD
Crizotinib—Decreased appetite—Hydrocortisone—gout	0.000496	0.00139	CcSEcCtD
Crizotinib—JAK3—Cytokine Signaling in Immune system—IL1RN—gout	0.000495	0.00294	CbGpPWpGaD
Crizotinib—Gastrointestinal disorder—Hydrocortisone—gout	0.000493	0.00138	CcSEcCtD
Crizotinib—Fatigue—Hydrocortisone—gout	0.000492	0.00137	CcSEcCtD
Crizotinib—Vision blurred—Prednisone—gout	0.000491	0.00137	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Prednisone—gout	0.000488	0.0463	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Prednisone—gout	0.000488	0.0463	CbGdCrCtD
Crizotinib—Paraesthesia—Methylprednisolone—gout	0.000482	0.00135	CcSEcCtD
Crizotinib—Anaemia—Prednisone—gout	0.000481	0.00134	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Prednisolone—gout	0.000476	0.0452	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Prednisolone—gout	0.000476	0.0452	CbGdCrCtD
Crizotinib—Dyspepsia—Methylprednisolone—gout	0.000472	0.00132	CcSEcCtD
Crizotinib—Syncope—Prednisone—gout	0.000467	0.0013	CcSEcCtD
Crizotinib—MAPK7—Immune System—NLRP3—gout	0.000463	0.00275	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—NLRP3—gout	0.000463	0.00275	CbGpPWpGaD
Crizotinib—Fatigue—Methylprednisolone—gout	0.000462	0.00129	CcSEcCtD
Crizotinib—LCK—Signaling by Interleukins—CASP1—gout	0.000462	0.00275	CbGpPWpGaD
Crizotinib—Loss of consciousness—Prednisone—gout	0.000457	0.00128	CcSEcCtD
Crizotinib—RIPK2—Cytokine Signaling in Immune system—CASP1—gout	0.000456	0.00271	CbGpPWpGaD
Crizotinib—Body temperature increased—Hydrocortisone—gout	0.000451	0.00126	CcSEcCtD
Crizotinib—PTK2B—Cytokine Signaling in Immune system—CASP1—gout	0.000449	0.00267	CbGpPWpGaD
Crizotinib—LCK—Signaling by Interleukins—IL1RN—gout	0.000447	0.00266	CbGpPWpGaD
Crizotinib—CDK7—Disease—PRPS2—gout	0.000445	0.00265	CbGpPWpGaD
Crizotinib—CDK7—Disease—PRPS1—gout	0.000445	0.00265	CbGpPWpGaD
Crizotinib—RIPK2—Cytokine Signaling in Immune system—IL1RN—gout	0.000441	0.00262	CbGpPWpGaD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	0.00044	0.00123	CcSEcCtD
Crizotinib—PTK2B—Cytokine Signaling in Immune system—IL1RN—gout	0.000435	0.00259	CbGpPWpGaD
Crizotinib—PTK2—Corticotropin-releasing hormone—POMC—gout	0.000427	0.00254	CbGpPWpGaD
Crizotinib—IKBKE—Innate Immune System—CASP1—gout	0.000427	0.00254	CbGpPWpGaD
Crizotinib—Oedema—Prednisone—gout	0.000425	0.00119	CcSEcCtD
Crizotinib—Infection—Prednisone—gout	0.000422	0.00118	CcSEcCtD
Crizotinib—Shock—Prednisone—gout	0.000418	0.00117	CcSEcCtD
Crizotinib—Nervous system disorder—Prednisone—gout	0.000417	0.00116	CcSEcCtD
Crizotinib—Skin disorder—Prednisone—gout	0.000413	0.00115	CcSEcCtD
Crizotinib—PTK2—Innate Immune System—NLRP3—gout	0.000411	0.00244	CbGpPWpGaD
Crizotinib—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	0.00041	0.00244	CbGpPWpGaD
Crizotinib—Asthenia—Hydrocortisone—gout	0.00041	0.00114	CcSEcCtD
Crizotinib—YES1—Innate Immune System—NLRP3—gout	0.000405	0.00241	CbGpPWpGaD
Crizotinib—Diarrhoea—Hydrocortisone—gout	0.000391	0.00109	CcSEcCtD
Crizotinib—MAPK7—Innate Immune System—CASP1—gout	0.000388	0.00231	CbGpPWpGaD
Crizotinib—LIMK1—Innate Immune System—CASP1—gout	0.000388	0.00231	CbGpPWpGaD
Crizotinib—Dizziness—Prednisolone—gout	0.000387	0.00108	CcSEcCtD
Crizotinib—Asthenia—Methylprednisolone—gout	0.000385	0.00107	CcSEcCtD
Crizotinib—IRAK1—Innate Immune System—NLRP3—gout	0.000384	0.00228	CbGpPWpGaD
Crizotinib—Paraesthesia—Prednisone—gout	0.000381	0.00107	CcSEcCtD
Crizotinib—TBK1—Immune System—NLRP3—gout	0.000378	0.00225	CbGpPWpGaD
Crizotinib—Dizziness—Hydrocortisone—gout	0.000378	0.00105	CcSEcCtD
Crizotinib—Dyspepsia—Prednisone—gout	0.000374	0.00104	CcSEcCtD
Crizotinib—TYK2—Innate Immune System—NLRP3—gout	0.000373	0.00222	CbGpPWpGaD
Crizotinib—Decreased appetite—Prednisone—gout	0.000369	0.00103	CcSEcCtD
Crizotinib—Rash—Prednisolone—gout	0.000369	0.00103	CcSEcCtD
Crizotinib—Dermatitis—Prednisolone—gout	0.000368	0.00103	CcSEcCtD
Crizotinib—Diarrhoea—Methylprednisolone—gout	0.000367	0.00103	CcSEcCtD
Crizotinib—Fatigue—Prednisone—gout	0.000366	0.00102	CcSEcCtD
Crizotinib—Constipation—Prednisone—gout	0.000363	0.00101	CcSEcCtD
Crizotinib—Vomiting—Hydrocortisone—gout	0.000363	0.00101	CcSEcCtD
Crizotinib—MAP3K3—Immune System—NLRP3—gout	0.000363	0.00216	CbGpPWpGaD
Crizotinib—Rash—Hydrocortisone—gout	0.00036	0.00101	CcSEcCtD
Crizotinib—Dermatitis—Hydrocortisone—gout	0.00036	0.001	CcSEcCtD
Crizotinib—Dizziness—Methylprednisolone—gout	0.000355	0.000991	CcSEcCtD
Crizotinib—YES1—Cytokine Signaling in Immune system—CASP1—gout	0.000353	0.0021	CbGpPWpGaD
Crizotinib—Nausea—Prednisolone—gout	0.000347	0.00097	CcSEcCtD
Crizotinib—JAK3—Immune System—NLRP3—gout	0.000342	0.00203	CbGpPWpGaD
Crizotinib—YES1—Cytokine Signaling in Immune system—IL1RN—gout	0.000342	0.00203	CbGpPWpGaD
Crizotinib—Vomiting—Methylprednisolone—gout	0.000341	0.000953	CcSEcCtD
Crizotinib—Nausea—Hydrocortisone—gout	0.000339	0.000947	CcSEcCtD
Crizotinib—Rash—Methylprednisolone—gout	0.000338	0.000945	CcSEcCtD
Crizotinib—Dermatitis—Methylprednisolone—gout	0.000338	0.000944	CcSEcCtD
Crizotinib—Body temperature increased—Prednisone—gout	0.000336	0.000938	CcSEcCtD
Crizotinib—IRAK1—Cytokine Signaling in Immune system—CASP1—gout	0.000335	0.00199	CbGpPWpGaD
Crizotinib—TXK—Immune System—CASP1—gout	0.000328	0.00195	CbGpPWpGaD
Crizotinib—TYK2—Cytokine Signaling in Immune system—CASP1—gout	0.000325	0.00193	CbGpPWpGaD
Crizotinib—IRAK1—Cytokine Signaling in Immune system—IL1RN—gout	0.000324	0.00193	CbGpPWpGaD
Crizotinib—Nausea—Methylprednisolone—gout	0.000319	0.00089	CcSEcCtD
Crizotinib—TXK—Immune System—IL1RN—gout	0.000318	0.00189	CbGpPWpGaD
Crizotinib—TBK1—Innate Immune System—CASP1—gout	0.000317	0.00189	CbGpPWpGaD
Crizotinib—TYK2—Cytokine Signaling in Immune system—IL1RN—gout	0.000315	0.00187	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—NLRP3—gout	0.000305	0.00181	CbGpPWpGaD
Crizotinib—Asthenia—Prednisone—gout	0.000305	0.000851	CcSEcCtD
Crizotinib—TYK2—Disease—PRPS2—gout	0.000303	0.0018	CbGpPWpGaD
Crizotinib—TYK2—Disease—PRPS1—gout	0.000303	0.0018	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—NLRP3—gout	0.000302	0.0018	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—NLRP3—gout	0.000301	0.00179	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—NLRP3—gout	0.0003	0.00179	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—ABCG2—gout	0.000298	0.00177	CbGpPWpGaD
Crizotinib—BLK—Immune System—NLRP3—gout	0.000293	0.00174	CbGpPWpGaD
Crizotinib—FGR—Immune System—NLRP3—gout	0.000292	0.00174	CbGpPWpGaD
Crizotinib—Diarrhoea—Prednisone—gout	0.000291	0.000812	CcSEcCtD
Crizotinib—PRKD1—Metabolism of lipids and lipoproteins—POMC—gout	0.000287	0.0017	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—NLRP3—gout	0.000283	0.00168	CbGpPWpGaD
Crizotinib—Dizziness—Prednisone—gout	0.000281	0.000785	CcSEcCtD
Crizotinib—Vomiting—Prednisone—gout	0.00027	0.000754	CcSEcCtD
Crizotinib—Rash—Prednisone—gout	0.000268	0.000748	CcSEcCtD
Crizotinib—Dermatitis—Prednisone—gout	0.000268	0.000747	CcSEcCtD
Crizotinib—LYN—Cytokine Signaling in Immune system—CASP1—gout	0.000263	0.00156	CbGpPWpGaD
Crizotinib—RIPK2—Innate Immune System—CASP1—gout	0.000256	0.00152	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—IL1RN—gout	0.000255	0.00151	CbGpPWpGaD
Crizotinib—Nausea—Prednisone—gout	0.000252	0.000705	CcSEcCtD
Crizotinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000251	0.00149	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—CASP1—gout	0.000248	0.00148	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—NLRP3—gout	0.000248	0.00147	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—CASP1—gout	0.000246	0.00146	CbGpPWpGaD
Crizotinib—FGR—Innate Immune System—CASP1—gout	0.000245	0.00146	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—IL1RN—gout	0.000241	0.00143	CbGpPWpGaD
Crizotinib—PTK2—Immune System—NLRP3—gout	0.000239	0.00142	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—IL1RN—gout	0.000238	0.00142	CbGpPWpGaD
Crizotinib—YES1—Immune System—NLRP3—gout	0.000236	0.0014	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	0.000231	0.00137	CbGpPWpGaD
Crizotinib—JAK2—Disease—PRPS2—gout	0.000229	0.00136	CbGpPWpGaD
Crizotinib—JAK2—Disease—PRPS1—gout	0.000229	0.00136	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—CASP1—gout	0.000226	0.00134	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—CASP1—gout	0.000226	0.00134	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—NLRP3—gout	0.000224	0.00133	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—NLRP3—gout	0.000219	0.0013	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—IL1RN—gout	0.000219	0.0013	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—IL1RN—gout	0.000219	0.0013	CbGpPWpGaD
Crizotinib—TYK2—Immune System—NLRP3—gout	0.000217	0.00129	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—CASP1—gout	0.000216	0.00128	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—IL1RN—gout	0.000209	0.00124	CbGpPWpGaD
Crizotinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—gout	0.000204	0.00121	CbGpPWpGaD
Crizotinib—LCK—Disease—PRPS1—gout	0.000201	0.00119	CbGpPWpGaD
Crizotinib—LCK—Disease—PRPS2—gout	0.000201	0.00119	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—CASP1—gout	0.000201	0.00119	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—CASP1—gout	0.000198	0.00118	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	0.000188	0.00112	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	0.000188	0.00112	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—CASP1—gout	0.000188	0.00112	CbGpPWpGaD
Crizotinib—TBK1—Immune System—CASP1—gout	0.000185	0.0011	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—CASP1—gout	0.000182	0.00108	CbGpPWpGaD
Crizotinib—TBK1—Immune System—IL1RN—gout	0.000179	0.00106	CbGpPWpGaD
Crizotinib—SRC—Disease—PRPS1—gout	0.000178	0.00106	CbGpPWpGaD
Crizotinib—SRC—Disease—PRPS2—gout	0.000178	0.00106	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—CASP1—gout	0.000177	0.00105	CbGpPWpGaD
Crizotinib—LYN—Immune System—NLRP3—gout	0.000176	0.00105	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NLRP3—gout	0.000175	0.00104	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—IL1RN—gout	0.000171	0.00102	CbGpPWpGaD
Crizotinib—JAK3—Immune System—CASP1—gout	0.000167	0.000993	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NLRP3—gout	0.000165	0.000979	CbGpPWpGaD
Crizotinib—JAK3—Immune System—IL1RN—gout	0.000162	0.000962	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—POMC—gout	0.00015	0.000891	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—CASP1—gout	0.000149	0.000885	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—CASP1—gout	0.000147	0.000877	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—CASP1—gout	0.000147	0.000873	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—CASP1—gout	0.000147	0.000872	CbGpPWpGaD
Crizotinib—LCK—Immune System—NLRP3—gout	0.000144	0.000857	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL1RN—gout	0.000144	0.000857	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—BCKDHA—gout	0.000143	0.000852	CbGpPWpGaD
Crizotinib—BLK—Immune System—CASP1—gout	0.000143	0.000851	CbGpPWpGaD
Crizotinib—FGR—Immune System—CASP1—gout	0.000143	0.000849	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	0.000143	0.000848	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL1RN—gout	0.000142	0.000845	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL1RN—gout	0.000139	0.000825	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL1RN—gout	0.000138	0.000822	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—CASP1—gout	0.000138	0.000821	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	0.000133	0.000788	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—POMC—gout	0.000128	0.000759	CbGpPWpGaD
Crizotinib—SRC—Immune System—NLRP3—gout	0.000128	0.000759	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—POMC—gout	0.000127	0.000758	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—POMC—gout	0.000121	0.000721	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—CASP1—gout	0.000121	0.000719	CbGpPWpGaD
Crizotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000117	0.000695	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CASP1—gout	0.000117	0.000695	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PRPS2—gout	0.000117	0.000695	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—HPRT1—gout	0.000117	0.000695	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PRPS1—gout	0.000117	0.000695	CbGpPWpGaD
Crizotinib—YES1—Immune System—CASP1—gout	0.000115	0.000685	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL1RN—gout	0.000113	0.000673	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL1RN—gout	0.000112	0.000663	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CASP1—gout	0.000109	0.00065	CbGpPWpGaD
Crizotinib—CYP3A5—Biological oxidations—POMC—gout	0.000108	0.000644	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—BCKDHA—gout	0.000108	0.000643	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—CASP1—gout	0.000107	0.000636	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—POMC—gout	0.000107	0.000635	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—POMC—gout	0.000107	0.000635	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CASP1—gout	0.000106	0.000631	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL1RN—gout	0.000106	0.000629	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL1RN—gout	0.000103	0.000611	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—POMC—gout	0.000101	0.000602	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—POMC—gout	9.86e-05	0.000586	CbGpPWpGaD
Crizotinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	9.47e-05	0.000563	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—POMC—gout	9.26e-05	0.00055	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—POMC—gout	8.96e-05	0.000532	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PRPS1—gout	8.81e-05	0.000524	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PRPS2—gout	8.81e-05	0.000524	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HPRT1—gout	8.81e-05	0.000524	CbGpPWpGaD
Crizotinib—LYN—Immune System—CASP1—gout	8.59e-05	0.000511	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CASP1—gout	8.55e-05	0.000508	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL1RN—gout	8.32e-05	0.000495	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL1RN—gout	8.28e-05	0.000492	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—POMC—gout	8.09e-05	0.000481	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CASP1—gout	8.04e-05	0.000478	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL1RN—gout	7.79e-05	0.000463	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—POMC—gout	7.32e-05	0.000435	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—POMC—gout	7.16e-05	0.000426	CbGpPWpGaD
Crizotinib—LCK—Immune System—CASP1—gout	7.04e-05	0.000419	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	6.96e-05	0.000414	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1RN—gout	6.82e-05	0.000405	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—BCKDHA—gout	6.66e-05	0.000396	CbGpPWpGaD
Crizotinib—SRC—Immune System—CASP1—gout	6.23e-05	0.000371	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1RN—gout	6.04e-05	0.000359	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—POMC—gout	5.69e-05	0.000338	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HPRT1—gout	5.43e-05	0.000323	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PRPS2—gout	5.43e-05	0.000323	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PRPS1—gout	5.43e-05	0.000323	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—POMC—gout	5.29e-05	0.000315	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—POMC—gout	5.03e-05	0.000299	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—POMC—gout	4.75e-05	0.000282	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—POMC—gout	4.72e-05	0.00028	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—POMC—gout	4.65e-05	0.000276	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—POMC—gout	4.45e-05	0.000264	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ABCG2—gout	4.32e-05	0.000257	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—POMC—gout	4.31e-05	0.000256	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—POMC—gout	4.31e-05	0.000256	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—POMC—gout	3.7e-05	0.00022	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—POMC—gout	3.65e-05	0.000217	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—POMC—gout	3.46e-05	0.000206	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—POMC—gout	3.36e-05	0.0002	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ABCG2—gout	3.26e-05	0.000194	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—POMC—gout	2.72e-05	0.000162	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—POMC—gout	2.55e-05	0.000151	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—POMC—gout	2.23e-05	0.000133	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCG2—gout	2.01e-05	0.000119	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—POMC—gout	1.97e-05	0.000117	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—POMC—gout	1.85e-05	0.00011	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—POMC—gout	1.4e-05	8.31e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—POMC—gout	8.61e-06	5.12e-05	CbGpPWpGaD
